221 related articles for article (PubMed ID: 34708888)
1. Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: A cohort study.
Xiao Z; Gong R; Chen X; Xiao D; Luo S; Ji Y
J Clin Lab Anal; 2021 Dec; 35(12):e24049. PubMed ID: 34708888
[TBL] [Abstract][Full Text] [Related]
2. Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
Teng CL; Young JH; Hsu SL; Chou G; Kuo IT; Yu CY; Hwang GY
J Chin Med Assoc; 2006 Nov; 69(11):534-7. PubMed ID: 17116616
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.
Xu LH; Guo Y; Cen JN; Yan WY; He HL; Niu YN; Lin YX; Chen CS; Hu SY
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4841-50. PubMed ID: 26744876
[TBL] [Abstract][Full Text] [Related]
4. [The Relationship between Body Mass Index and Adult Acute Myeloid Leukemia].
Wang YN; Wei T; Xi YM; Yang MY; Niu L; Wang XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):677-684. PubMed ID: 34105456
[TBL] [Abstract][Full Text] [Related]
5. The expression and clinical significance of CD59 and FLAER in Chinese adult AML patients.
Li L; Yu S; Liu S; Meng F; Ren X; Liu Z; Fu R
J Clin Lab Anal; 2022 Jan; 36(1):e24145. PubMed ID: 34935195
[TBL] [Abstract][Full Text] [Related]
6. Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: a retrospective cohort study.
Xiao Z; Li H; Xiao D; Liu Y; Chen X; Luo S; Ji Y
BMC Cancer; 2022 Nov; 22(1):1127. PubMed ID: 36324111
[TBL] [Abstract][Full Text] [Related]
7. Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Dean R; Sweetenham J; Andresen S; Sobecks R; Sekeres MA; Advani A; Brown S; Bolwell B
Bone Marrow Transplant; 2007 Oct; 40(8):753-8. PubMed ID: 17700600
[TBL] [Abstract][Full Text] [Related]
8. Serum LDH value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly.
Ferrara F; Mirto S
Br J Haematol; 1996 Mar; 92(3):627-31. PubMed ID: 8616027
[TBL] [Abstract][Full Text] [Related]
9. Serum lactate dehydrogenase fails to predict response to treatment and survival in acute non-lymphocytic leukemia.
Fasola G; Zuffa E; Fanin R; Michieli M; Gallizia C; Damiani D; Russo D; Visani G; Resegotti L; Comotti B
Int J Biol Markers; 1989; 4(3):142-9. PubMed ID: 2614082
[TBL] [Abstract][Full Text] [Related]
10. The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy.
Chen Y; Yang T; Zheng X; Yang X; Zheng Z; Zheng J; Liu T; Hu J
Medicine (Baltimore); 2016 Jul; 95(30):e4182. PubMed ID: 27472687
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of serum lactate dehydrogenase and its isozymes in monitoring the therapy in patients with acute leukemia.
Pandit MK; Joshi BH; Patel PS; Chitnis KE; Balar DB
Indian J Pathol Microbiol; 1990 Jan; 33(1):41-7. PubMed ID: 2394475
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers in leukemia: evaluation of serum levels of different forms of sialic acid, Regan isoenzyme and lactate dehydrogenase.
Patel PS; Adhvaryu SG; Baxi BR
Int J Biol Markers; 1991; 6(3):177-82. PubMed ID: 1791311
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.
Wimazal F; Sperr WR; Kundi M; Meidlinger P; Fonatsch C; Jordan JH; Thalhammer-Scherrer R; Schwarzinger I; Geissler K; Lechner K; Valent P
Leuk Res; 2001 Apr; 25(4):287-94. PubMed ID: 11248325
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.
Wimazal F; Sperr WR; Kundi M; Vales A; Fonatsch C; Thalhammer-Scherrer R; Schwarzinger I; Valent P
Ann Oncol; 2008 May; 19(5):970-6. PubMed ID: 18272915
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee NY; Suh JS; Chae SC; Lee KS; Lee KB
Leuk Lymphoma; 2005 Jun; 46(6):885-91. PubMed ID: 16019534
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Lactate Dehydrogenase for Mid-Term Mortality in Acute Decompensated Heart Failure: A Comparison to Established Biomarkers and Brain Natriuretic Peptide.
Yamaguchi S; Abe M; Arakaki T; Arasaki O; Shimabukuro M
Heart Lung Circ; 2020 Sep; 29(9):1318-1327. PubMed ID: 31862227
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
18. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study.
Lu J; Wei Z; Jiang H; Cheng L; Chen Q; Chen M; Yan J; Sun Z
J Surg Res; 2018 Aug; 228():314-321. PubMed ID: 29907227
[TBL] [Abstract][Full Text] [Related]
19. Serum Lactate Dehydrogenase Can Be Used as a Factor for Re-Evaluating First-Relapsed Multiple Myeloma.
Liu Y; Wen L; Chen H; Chen Y; Duan W; Kang Y; Ma L; Huang X; Lu J
Acta Haematol; 2020; 143(6):559-566. PubMed ID: 32610311
[TBL] [Abstract][Full Text] [Related]
20. Selection of elderly acute myeloid leukemia patients for intensive chemotherapy: effectiveness of intensive chemotherapy and subgroup analysis.
Kim DS; Kang KW; Yu ES; Kim HJ; Kim JS; Lee SR; Park Y; Sung HJ; Yoon SY; Choi CW; Kim BS
Acta Haematol; 2015; 133(3):300-9. PubMed ID: 25470986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
